Tracking GLP-1 Use in Breast Cancer Care

Obesity is a well-known risk factor for breast cancer development and recurrence, and glucagon-like peptide 1 (GLP-1) receptor agonists have emerged as effective treatments for weight management. At the 2025 San Antonio Breast Cancer…